Effects of microinjection of angiotensin II and captopril to VTA on morphine self-administration in rats

Acta Biologica Hungarica

Volumn 60, Issue 3, 2009, Pages 241-252

  Hosseini, M ^a   Alaei, H A ^b   Havakhah, Shahrzad ^a   Neemati Karimooy, H A ^a   Gholamnezhad, Zahra ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin II; Captopril; Morphine; Rat; Self administration; VTA

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; MORPHINE; NARCOTIC ANALGESIC AGENT;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; DRUG SELF ADMINISTRATION; INJECTION; MALE; RAT; REWARD; VENTRAL TEGMENTUM; WISTAR RAT;

ANALGESICS, OPIOID; ANGIOTENSIN II; ANIMALS; BEHAVIOR, ANIMAL; CAPTOPRIL; INJECTIONS; MALE; MORPHINE; RATS; RATS, WISTAR; REWARD; SELF ADMINISTRATION; VENTRAL TEGMENTAL AREA;

EID: 70349785790     PISSN: 02365383     EISSN: 1588256X     Source Type: Journal    
DOI: 10.1556/ABiol.60.2009.3.1     Document Type: Article

References (53)

1. Alaei, H., Esmaeili, M., Nasimi, A., Pourshanazari, A. (2005) Ascorbic acid decreases morphine selfadministration and withdrawal symptoms in rats. Pathophysiology 12, 103-107.
2. Alaei, H., Hosseini, M. (2007) Angiotensin converting enzyme inhibitor captopril modifies conditioned place preference induced by morphine and morphine withdrawal signs in rats. Pathophysiology 14, 55-60.
3. Allen, A. M., MacGregor, D. P., McKinley, M. J., Mendelsohn, F. A. (1999) Angiotensin II receptors in the human brain. Regul. Pept. 79, 1-7.
4. Barnes, J. M., Barnes, N. M., Costall, B. (1990) Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition. Brain Res. 507, 341-343.
5. Di Chiara, G., Bassareo, V. (2007) Reward system and addiction: what dopamine does and doesn't do. Curr. Opin. Pharmacol. 2, 233.
6. Diana, M., Muntoni, A. L., Pistis, M., Melis, M., Gessa, G. L. (1999) Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. Eur. J. Neurosci. 11, 1037-1041.
7. Fitts, D. A. (1993) Angiotensin and captopril increase alcohol intake. Pharmacol. Biochem. Behav. 45, 35-43.
8. Gard, P. R. (2002) The role of angiotensin II in cognition and behaviour. Eur. J. Pharmacol. 438, 4381-4414.
9. Georgiev, V. P., Lazarova, M. B., Kambourova, T. (1995) Further evidence for the interactions between angiotensin II and GABAergic transmission in pentylenetetrazol kindling seizures in mice. Neuropeptides 28, 29-34.
10. Georgieva, D., Georgiev, V. (1999) The role of angiotensin II and of its receptor subtypes in the acetic acid-induced abdominal constriction test. Pharmacol. Biochem. Behav. 62, 229-232.
11. Giardina, W. J., Ebert, D. M. (1989) Positive effects of captopril in the behavioral despair swim test. Biol. Psychiatry 25, 697-702.
12. Grove, K. L., Speth, R. C., Palmer, A. A., Ganong, W. F., Steele, M. K. (1998) Angiotensin II receptor binding sites in the ventral portion of the bed nucleus of the stria terminalis are reduced by interruption of the medial forebrain bundle. Brain Res. 809, 5-11.
13. Grupp, L. A., Killian, M., Perlanski, E., Stewart, R. B. (1988) Angiotensin II reduces voluntary alcohol intake in the rat. Pharmacol. Biochem. Behav. 29, 479-482.
14. Hadjiivanova, C. H., Georgiev, V. (1998) In vitro effect of angiotensin II on GABA release in rat hippocampus. Neuropeptides 32, 431-434.
15. Han, N. L., Luo, F., Bian, Z. P., Han, J. S. (2000) Synergistic effect of cholecystokinin octapeptide and angiotensin II in reversal of morphine induced analgesia in rats. Pain. 85, 465-469.
16. Holy, Z., Wisniewski, K. (2001) Examination of the influence of 3,5-DHPG on behavioral activity of angiotensin II. Pol. J. Pharmacol. 53, 235-243.
17. Hosseini, M., Sharifi, M. R., Alaei, H., Shafei, M. N., Nemati Karimooy, H. A. (2007) Effects of angiotensin II and captopril on rewarding properties of morphine. Indian J. Exp. Biol. 45, 770-777.
18. Ikemoto, S. (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev. 56, 27-78.
19. Jenkins, T. A., Mendelsohn, F. A., Chai, S. Y. (1997) Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J. Neurochem. 68, 1304-1311.
20. Johnson, S. W., North, R. A. (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483-488.
21. Jones, D. L. (1986) Central integration of cardiovascular and drinking responses elicited by central administration of angiotensin II: divergence of regulation by the ventral tegmental area and nucleus accumbens. Can. J. Physiol. Pharmacol. 64, 1011-1016.
22. Kaada, B., Woie, L. (1990) Effects of an angiotensin converting enzyme (ACE) inhibitor on plasma endorphin level. Gen. Pharmacol. 21, 693-695.
23. Kalivas, P. W., Nakamura, M. (1999) Neural systems for behavioral activation and reward. Curr. Opin. Neurobiol. 9, 223-227.
24. Kalivas, P. W. (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Brain Res. Rev. 18, 75-113.
25. Kenny, P. J., Chartoff, E., Roberto, M., Carlezon, W. A. Jr. Markou. NMDA Receptors Regulate Nicotine-Enhanced Brain Reward Function and Intravenous Nicotine Self-Administration: Role of the Ventral Tegmental Area and Central Nucleus of the Amygdala. Neuropsychopharmacology 34, 266-281.
26. Kim, S. Y., Chudapongse, N., Lee, S. M., Levin, M. C., Oh, J. T., Park, H. J., Ho, I. K. (2005) Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res. Mol. Brain Res. 133, 58-70.
27. Koob, G. F., Nestler, E. J. (1997) The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9, 482-497.
28. Margolin, A., Avants, S. K., Setaro, J. F., Rinder, H. M., Grupp, L. (2000) Cocaine, HIV, and their cardiovascular effects: is there a role for ACE-inhibitor therapy? Drug Alcohol Depend. 61, 35-45.
29. Martin, P., Massol, J., Puech, A. J. (1990) Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats. Biol. Psychiatry 27, 968-974.
30. Maul, B., Krause, W., Pankow, K., Becker, M., Gembardt, F., Alenina, N., Walther, T., Bader, M., Siems, W. E. (2005) Central angiotensin II controls alcohol consumption via its AT1 receptor. FASEB J. 19, 1474-1481.
31. Maul, B., Siems, W.-E., Hoehe, M. R., Bader, M., Walther, T. (2001) Alcohol consumption is controlled by angiotensin II. FASEB J. 15, 1640-1642.
32. Mereu, G., Costa, E., Armstrong, D. M., Vicini, S. (1991) Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J. Neurosci. 11, 1359-1366.
33. Nikolova, J. G., Getova, D. P., Nikolov, F. P. (2000) Effects of ACE inhibitors on learning and memory processes in rats. Folia Med. (Plovdiv.) 42, 47-51.
34. Paxinos, G., Watson, C. (1998) The Rat Brain Streotaxic Coordinates. Academic Press, San Diego.
35. Prado, W. A., Pelegrini-da-Silva, A., Martins, A. R. (2003) Microinjection of renin-angiotensin system peptides in discrete sites within the rat periaqueductal gray matter elicits antinociception. Brain Res. 972, 207-215.
36. Raghavendra, V., Chopra, K., Kulkarni, S. K. (2001) Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides 35, 65-69.
37. Rajaei, Z., Alaei, H., Nasimi, A., Amini, H., Ahmadiani, A. (2005) Ascorbate reduces morphineinduced extracellular DOPAC level in the nucleus accumbens: A microdialysis study in rats. Brain Research 1053, 62-66.
38. Reardon, K. A., Mendelsohn, F. A., Chai, S. Y., Horne, M. K. (2000) The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease. Aust. N. Z. J. Med. 30, 48-53.
39. Sahraei, H., Poorheidari, G., Foadaddini, M., Khoshbaten, A., Asgari, A., Noroozzadeh, A., Ghoshooni, H., Firoozabadi, S. H., Zarrindast, M. R. (2004) Effects of nitric oxide on morphine selfadministration in rat. Pharmacol. Biochem. Behav. 77, 111-116.
40. Sahraei, H., Motamedi, F., Khoshbaten, A., Zarrindast, M. R. (1999) Adenosine A (2) receptors inhibit morphine self-administration in rats. Eur. J. Pharmacol. 383, 107-113.
41. Savaskan, E. (2005) The role of the brain renin-angiotensin system in neurodegenerative disorders. Curr. Alzheimer Res. 2, 29-35.
42. Tchekalarova, J., Pechlivanova, D., Kambourova, T., Matsoukas, J., Georgiev, V. (2003) The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception. Regul. Pept. 111, 191-197.
43. Toma, N., Sgambato, V., Couture, R. (1997) Ef fect of angiotensin II on a spinal nociceptive reflex in the rat: receptor and mechanism of action. Life Sci. 61, 503-513.
44. Van Ree, J. M., Gerrits, M. A., Vanderschuren, L. J. (1999) Opioids, reward and addiction: An encounter of biology, psychology, and medicine. Pharmacol. Rev. 51, 341-396.
45. Wang, H. L., Zhao, Y., Xiang, X. H., Wang, H. S., Wu, W. R. (2004) Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 1079-1087.
46. Weisinger, R. S., Blair-West, J. R., Denton, D. A., McBurnie, M. I. (1999) Angiotensin II stimulates intake of ethanol in C57BL/6J mice. Physiol. Behav. 67, 369-376.
47. Williams, J. T., Christie, M. J., Manzoni, O. (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81, 299-343.
48. Winnicka, M. M. (1999) Dopaminergic projection to the nucleus accumbens mediates the memoryenhancing effect of angiotensins in rats. Pharmacol. Biochem. Behav. 62, 625-630.
49. Winnicka, M. M., Braszko, J. J., Wisniewski, K. (1998) 6-OHDA lesions to amygdala and hippocampus attenuate memory-enhancing effect of the 3-7 fragment of angiotensin II. Gen. Pharmacol. 30, 801-805.
50. Winnicka, M. M., Wisniewski, K. (1999) Disruption of temporo-entorhinal connections abolishes the facilitatory effect of angiotensins on memory in rat. Pharmacol. Res. 40, 53-59.
51. Wise, R. A. (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend. 51, 13-22.
52. Wisniewski, K., Lutostanska, A., Artemowicz, B. (1996) The role of NMDA receptors in central action of angiotensin II. Acta Physiol. Hung. 84, 347-348.
53. Xi, Z. X., Stein, E. A. (2002) GABAergic mechanisms of opiate reinforcement. Alcohol 37, 485-494.